Competitor Analysis in Thrombolytics & Fibrinolytics Field Offered in In-Demand Report by La Merie Publishing

11 Jun 2013 • by Natalie Aster

A competitor analysis in the product portfolios and development pipelines of novel thrombolytics and fibrinolytics for treatment of cardiovascular thrombosis, stroke and eye diseases is available in the report “Competitor Analysis: Thrombolytics & Fibrinolytics” by La Merie Publishing.

Report Details:

Competitor Analysis: Thrombolytics & Fibrinolytics
Published: May, 2013
Pages: 38
Price: US$ 330.00

The report provides information on the various generation of marketed thrombolytics and includes a compilation of current active projects in research and development of novel thrombolytics and fibrinolytics including those in development in ophthalmology and in less regulated markets. In addition, the report lists company-specific product portfolios and R&D pipelines of thrombolytics and fibrinolytics.

Reports on this Issue:

• Competitor Analysis: Anthrax Vaccines & Therapeutics
• Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics
• Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)
• Competitor Analysis: Human Growth Hormone (hGH)
• Competitor Analysis: G-CSF and GM-CSF

More information can be found in the report “Competitor Analysis: Thrombolytics & Fibrinolytics” by La Merie Publishing.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com